Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design

The usage of fixed dose combination (FDC) tablets of Lamivudine and Tenofovir Disoproxil Fumarate (TDF) is increasing due to increased incidences of HIV/Hepatitis B and HIV/TB co-infections. This is likely to increase the financial crisis due to limited resources for funding procurement of ready-mad...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Heliyon
Huvudupphovsmän: Tibalinda, Prosper, Sempombe, Joseph, Shedafa, Raphael, Masota, Nelson, Pius, Dickson, Temu, Mary, Kaale, Eliangiringa
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5137174/
https://ncbi.nlm.nih.gov/pubmed/27942608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2016.e00207
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk